◀ Back to JUN
HLA-DRB1 — JUN
Text-mined interactions from Literome
Guan et al., Oncogene 2002
:
These results indicate that
AP-1 regulates
DR4 expression via the AP-1 binding site located at -350/-344
Yue et al., Cancer Biol Ther 2006
(Carcinoma, Non-Small-Cell Lung...) :
We previously demonstrated that CDDO-Me induces a
c-Jun N-terminal kinase (JNK) mediated
DR5 expression and apoptosis
Zou et al., Cancer Biol Ther 2007
(Carcinoma, Non-Small-Cell Lung...) :
In an effort to understand the mechanism by which CDDO-Me induces apoptosis, particularly in human lung cancer cells, we previously demonstrated that CDDO-Me induces apoptosis involving
c-Jun N-terminal kinase (JNK) dependent upregulation of
death receptor 5 (DR5) expression
Hwang et al., Amino Acids 2012
(Adenocarcinoma...) :
AW00179 potentiates TRAIL mediated death of human lung cancer H1299 cells through
ROS-JNK-c-Jun mediated up-regulation of
DR5 and down-regulation of anti-apoptotic molecules ... AW00179 also induced the activation of c-Jun and ERK ; however, a pharmacologic inhibition study revealed that
JNK-c-Jun signaling is
involved in the induction of
DR5 expression ... In conclusion, AW00179 has the potential to sensitize H1299 cells to TRAIL mediated apoptosis through two distinct mechanisms :
ROS-JNK-c-Jun mediated up-regulation of
DR5 , and down-regulation of anti-apoptotic molecules
Cheng et al., Cell cycle (Georgetown, Tex.) 2012
(Neoplasms) :
Induction of
DR4 and DR5 was independent of p53, Bax and Bim but was
dependent on
c-Jun N terminal kinase (JNK) as JNK pharmacological inhibition and siRNA abolished the induction of the TRAIL receptors by MMC
Portanova et al., Int J Oncol 2013
:
Notch inhibition restores TRAIL mediated apoptosis via
AP1 dependent upregulation of
DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells